Cohance Lifesciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman
Chairman
Cohance Lifesciences Limited
Equibles does not estimate personal net worth.
Umang Vora is recorded as Chairman at Cohance Lifesciences Limited. Umang Vora has spoken on 3 earnings calls across 1 company, most recently for Cohance Lifesciences Limited on November 6, 2026. Cohance Lifesciences Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Before I move to the speech, I'd like to say that we are deeply saddened by the loss of our colleague following the incident at our Surya Pate facility, and our thoughts are with his family and loved ones.”
“As we had indicated in our previous earnings call, Q1 of this year would be our lowest quarter ever, and that is how the quarter is laid out. From here onwards, we expect improvement in Q2 and the return to year-on-year growth from the second half.”
“Having spent over three decades in this industry, I'm excited to be part of a platform that is anchored in science with capabilities such as ADCs and oligonucleotides, which are well differentiated and hard to replicate in terms of a value offering.”
Cohance Lifesciences Limited
Chairman
Transcript header (unverified)
Cohance Lifesciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman
Earnings Call for the Quarter Ended September 30, 2026
Cohance Lifesciences Limited
Earnings Call
Cohance Lifesciences Limited
Earnings Call for the Quarter Ended March 31, 2026
Cohance Lifesciences Limited